These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9747135)

  • 21. ECG of the month. The hare and the tortoise. Atrial flutter with slow ventricular rate.
    Martinez-Lopez JI
    J La State Med Soc; 1999 Sep; 151(9):444-6. PubMed ID: 11284142
    [No Abstract]   [Full Text] [Related]  

  • 22. Difficulties in the interpretation of patch test reactions to ophthalmic beta-blockers.
    Carrière M; Giordano-Labadie F; Schwarze HP; Loche F; Bazex J
    Contact Dermatitis; 1998 Dec; 39(6):319-20. PubMed ID: 9874031
    [No Abstract]   [Full Text] [Related]  

  • 23. Allergic contact dermatitis due to the beta-blocker carteolol in eyedrops.
    Sánchez-Pérez J; Córdoba S; Bartolomé B; García-Díez A
    Contact Dermatitis; 1999 Nov; 41(5):298. PubMed ID: 10554073
    [No Abstract]   [Full Text] [Related]  

  • 24. Case book: palpitations.
    Conway D; Lip GY
    Practitioner; 2001 May; 245(1622):393-6, 398, 401. PubMed ID: 11373969
    [No Abstract]   [Full Text] [Related]  

  • 25. New topical beta-blockers for glaucoma.
    Drug Ther Bull; 1987 Aug; 25(16):63-4. PubMed ID: 2887414
    [No Abstract]   [Full Text] [Related]  

  • 26. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
    Trinquand C; Romanet JP; Nordmann JP; Allaire C;
    J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
    Maruyama K; Shirato S
    J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should beta blockers be abandoned as initial monotherapy in chronic open angle glaucoma? View 1.
    Anton A
    Br J Ophthalmol; 2002 Jun; 86(6):692-3; discussion 695. PubMed ID: 12075596
    [No Abstract]   [Full Text] [Related]  

  • 29. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
    Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
    Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Two cases of myokymia-like muscle movement disorders following administration of adrenergic beta-antagonists].
    Kakenuma M; Yoshikawa T
    Nihon Naika Gakkai Zasshi; 1998 Jan; 87(1):157-9. PubMed ID: 9513559
    [No Abstract]   [Full Text] [Related]  

  • 31. [Timolol eye drops].
    Taéron C
    Rev Infirm; 2006 Apr; (120):37-8. PubMed ID: 16700366
    [No Abstract]   [Full Text] [Related]  

  • 32. [ECG no. 107. What is your diagnosis? Paroxysmal atrial flutter in bradycardia. Pacemaker implantation is a good therapeutic option].
    Erne P
    Praxis (Bern 1994); 1999 May; 88(19):851-2. PubMed ID: 10409882
    [No Abstract]   [Full Text] [Related]  

  • 33. [Glaucoma: drug contraindications].
    Collignon J; Prijot E
    Rev Med Liege; 1985 May; 40(9):365-8. PubMed ID: 2862685
    [No Abstract]   [Full Text] [Related]  

  • 34. Should beta blockers be abandoned as initial monotherapy in chronic open angle glaucoma? View 2.
    Skuta GL
    Br J Ophthalmol; 2002 Jun; 86(6):693-4; discussion 695. PubMed ID: 12075597
    [No Abstract]   [Full Text] [Related]  

  • 35. Syncope and sinus bradycardia from combined use of thalidomide and beta-blocker.
    Yamaguchi T
    Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):1033-5. PubMed ID: 18613249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic and pharmacodynamic differences between ocular and nasal instillation of carteolol on intraocular pressure and heart rate in Japanese men with high CYP2D6 activity.
    Ishii Y; Nakamura K; Matsuki S; Uemura N; Muraguchi R; Nakagawa M; Nakano S; Nakatsuka K
    J Clin Pharmacol; 2002 Sep; 42(9):1020-6. PubMed ID: 12211218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary open angle glaucoma: an overview on medical therapy.
    Vetrugno M; Cantatore F; Ruggeri G; Ferreri P; Montepara A; Quinto A; Sborgia C
    Prog Brain Res; 2008; 173():181-93. PubMed ID: 18929109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Timolol maleate 0.5% versus timolol maleate in gel forming solution 0.5% (Timolol GFS) in open angle glaucoma in India. Preliminary safety and efficacy study.
    Kumar H; Sudan R; Sethi HS; Sony P
    Indian J Ophthalmol; 2002 Mar; 50(1):21-3. PubMed ID: 12090082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bradyarrhythmias secondary to topical levobunolol hydrochloride solution.
    Lin L; Wang Y; Chen Y; Liu M
    Clin Interv Aging; 2014; 9():1741-5. PubMed ID: 25342892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulation of carteolol chitosomes for ocular delivery: formulation optimization,
    Zafar A; Alruwaili NK; Imam SS; Alsaidan OA; Alharbi KS; Yasir M; Elmowafy M; Ansari MJ; Salahuddin M; Alshehri S
    Cutan Ocul Toxicol; 2021 Dec; 40(4):338-349. PubMed ID: 34340615
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.